IP Library Granted Patent US 8,034,604
Granted Patent B2
US 8,034,604 · App. 12/961,052 · Granted Oct 11, 2011

High viscosity xanthan polymer preparations

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,034,604
App. No.
12/961,052
Granted
Oct 11, 2011
Kind
B2
Abstract

Increasing the molecular length of xanthan polymer makes a higher viscosity xanthan composition. Xanthan with higher specific viscosity characteristics provides more viscosity at equivalent concentration in food, industrial and oilfield applications. Methods for increasing the viscosity of xanthan include inducing particular key genes and increasing copy number of particular key genes.

Claims (20)

1. A recombinant Xanthomonas campestris culture having multiple copies of gumB and gumC, wherein said recombinant Xanthomonas campestris culture produces unpasteurized xanthan molecules having an intrinsic viscosity which is at least 20% greater than xanthan from a corresponding strain of Xanthomonas campestris not having multiple copies of gumB and gumC.

2. The recombinant Xanthomonas campestris culture of claim 1 , wherein said unpasteurized xanthan molecules have an intrinsic viscosity which is at least 25% greater than xanthan from a corresponding strain of Xanthomonas campestris not having multiple copies of gumB and gumC.

3. The recombinant Xanthomonas campestris culture of claim 1 , wherein said unpasteurized xanthan molecules have an intrinsic viscosity which is at least 30% greater than xanthan from a corresponding strain of Xanthomonas campestris not having multiple copies of gumB and gumC.

4. The recombinant Xanthomonas campestris culture of claim 1 , wherein said unpasteurized xanthan molecules are in a product selected from the group consisting of food selected from the group consisting of a salad dressing, a syrup, a juice drink, and a frozen dessert, a printing dye, an oil drilling, a ceramic glaze, and a pharmaceutical composition in a controlled-released formulation.

5. A recombinant Xanthomonas campestris culture having multiple copies of gumB and gumC, wherein said recombinant Xanthomonas campestris culture produces an unpasteurized xanthan composition comprising a population of xanthan molecules having a range of molecular lengths, wherein at least 1% of the population has a length of at least 3 μm as measured by atomic force microscopy.

6. The recombinant Xanthomonas campestris culture of claim 5 , wherein said unpasteurized xanthan composition comprises a population of xanthan molecules having a range of molecular lengths, wherein at least 1% of the population has a length of at least 4 μm as measured by atomic force Microscopy.

7. The recombinant Xanthomonas campestris culture of claim 5 , wherein said unpasteurized xanthan composition comprises a population of xanthan molecules having a range of molecular lengths, wherein at least 1% of the population has a length of at least 5 μm as measured by atomic force microscopy.

8. The recombinant Xanthomonas campestris culture of claim 5 , wherein said unpasteurized xanthan composition comprises a population of xanthan molecules having a range of molecular lengths, wherein at least 1% of the population has a length of at least 7 μm as measured by atomic force microscopy.

9. The recombinant Xanthomonas campestris culture of claim 5 , wherein said unpasteurized xanthan composition comprises a population of xanthan molecules having a range of molecular lengths, wherein at least 5% of the population has a length of at least 3 μm as measured by atomic force microscopy.

10. The recombinant Xanthomonas campestris culture of claim 5 , wherein said unpasteurized xanthan composition comprises a population of xanthan molecules having a range of molecular lengths, wherein at least 10% of the population has a length of at least 3 μm as measured by atomic force microscopy.

11. The recombinant Xanthomonas campestris culture of claim 5 , wherein said unpasteurized xanthan composition comprises a population of xanthan molecules having a range of molecular lengths, wherein at least 15% of the population has a length of at least 3 μm as measured by atomic force microscopy.

12. The recombinant Xanthomonas campestris culture of claim 5 , wherein said unpasteurized xanthan composition comprises a population of xanthan molecules having a range of molecular lengths, wherein at least 20% of the population has a length of at least 3 μm as measured by atomic force microscopy.

13. The recombinant Xanthomonas campestris culture of claim 5 , wherein said unpasteurized xanthan composition is in a product selected from the group consisting of food selected from the group, consisting of a salad dressing, a syrup, a juice drink, and a frozen dessert, a printing dye, an oil drilling, a ceramic glaze, and a pharmaceutical composition in a controlled-released formulation.

14. A recombinant Xanthomonas campestris culture having multiple copies of gumB and gumC, wherein said recombinant Xanthomonas campestris culture produces unpasteurized xanthan molecules having a seawater viscosity which is at least 10% greater than xanthan from a corresponding strain of Xanthomonas campestris not having multiple copies of gumB and gumC.

15. The recombinant Xanthomonas campestris culture of claim 14 , wherein said unpasteurized xanthan molecules have a seawater viscosity which is at least 15% greater than xanthan from a corresponding strain of Xanthomonas campestris not having multiple copies of gumB and gumC.

16. The recombinant Xanthomonas campestris culture of claim 14 , wherein said unpasteurized xanthan molecules are composed of a product selected from the group consisting of food selected from the group consisting of a salad dressing, a syrup, a juice drink, and a frozen dessert, a printing dye, an oil drilling, a ceramic glaze, and a pharmaceutical composition in a controlled-released formulation.

17. The recombinant Xanthomonas campestris culture of claim 14 , wherein said recombinant Xanthomonas campestris culture produces unpasteurized xanthan molecules having a seawater viscosity of DR>25 when the seawater viscosity is measured in a solution of 41.95 g of sea salt per 1 liter deionized water and at a concentration of 0.86 g xanthan per liter.

18. The recombinant Xanthomonas campestris culture of claim 17 , wherein said unpasteurized xanthan molecules are in a product selected from the group consisting of food selected from the group consisting of a salad dressing, a syrup, a juice drink, and a frozen dessert, a printing dye, an oil drilling, a ceramic glaze, and a pharmaceutical composition in a controlled-released formulation.

19. The recombinant Xanthomonas campestris culture of claim 1 , wherein said multiple copies of gumB and gumC are integrated into a genome of a wild-type Xanthomonas campestris strain, and wherein gum B and gum C are overexpressed.

20. The recombinant Xanthomonas campestris culture of claim 1 , wherein said recombinant Xanthomonas campestris culture does not produce an increased amount of gene product selected from the group consisting of orfX and gumD-gumG.

Assignments (5)
RELEASE OF SECURITY INTEREST IN PATENTS Recorded Jun 27, 2014
From: WELLS FARGO BANK, NATIONAL ASSOCIATION
To: J.M. HUBER CORPORATION; CP KELCO U.S., INC.; HUBER ENGINEERED WOODS LLC
Reel/Frame 033247/0705 →
SECURITY INTEREST Recorded Nov 8, 2011
From: J.M. HUBER CORPORATION; CP KELCO U.S., INC.; HUBER ENGINEERED WOODS LLC
To: WELLS FARGO BANK, NATIONAL ASSOCIATION, AS AGENT
Reel/Frame 027279/0114 →
RELEASE OF SECURITY INTEREST Recorded Nov 1, 2011
From: BANK OF AMERICA, N.A.
To: J.M. HUBER CORPORATION; 333 ASSOCIATES LLC; 333 PARTNERS LLC; CELTEGAN LLC; CP KELCO U.S., INC.; HUBER CST COMPANY; HUBER CST CORPORATION; HUBER ENERGY L.P.; HUBER ENERGY LLC; HUBER ENGINEERED WOODS LLC; HUBER EQUITY CORPORATION; HUBER INTERNATIONAL CORP.; HUBER RESOURCES CORP.; HUBER SOUTH TEXAS GP, LLC; HUBER SOUTH TEXAS LP, LLC; HUBER TIMBER INVESTMENTS LLC; HUBER TIMBER LLC; J.M. HUBER MICROPOWDERS INC.; JMH PARTNERS CORP.; KELCO COMPANY; ST. PAMPHILE TIMBER LLC; TABSUM, INC.; TARA INSURANCE GLOBAL LIMITED; QUINCY WAREHOUSES, INC. (FORMERLY UNDERGROUND WAREHOUSES, INC.
Reel/Frame 027158/0142 →
SECURITY AGREEMENT Recorded Mar 29, 2011
From: J.M. HUBER CORPORATION; 333 ASSOCIATES LLC; 333 PARTNERS LLC; CELTEGAN LLC; CP KELCO U.S., INC.; HUBER CST COMPANY; HUBER CST CORPORATION; HUBER ENERGY L.P.; HUBER ENERGY LLC; HUBER ENGINEERED WOODS LLC; HUBER EQUITY CORPORATION; HUBER INTERNATIONAL CORP.; HUBER RESOURCES CORP.; HUBER SOUTH TEXAS GP, LLC; HUBER SOUTH TEXAS LP, LLC; HUBER TIMBER INVESTMENTS LLC; HUBER TIMBER LLC; J.M. HUBER MICROPOWDERS INC.; JMH PARTNERS CORP.; KELCO COMPANY; ST. PAMPHILE TIMBER LLC; TABSUM, INC.; TARA INSURANCE GLOBAL LIMITED; UNDERGROUND WAREHOUSES, INC.
To: BANK OF AMERICA, N.A.
Reel/Frame 026042/0063 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 31, 2011
From: PATEL, YAMINI; SCHNEIDER, JANE C.; IELPI, LUIS; IELMINI, MARIA VERONIC
To: CP KELCO U.S., INC.; FUNDACION INSTITUTO LELOIR
Reel/Frame 025721/0001 →